Production (Stage)
Xtant Medical Holdings, Inc.
XTNT
$0.7368
$0.01031.42%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.41% | 12.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.41% | 12.80% | |||
| Cost of Revenue | -18.26% | 33.18% | |||
| Gross Profit | 26.33% | -1.74% | |||
| SG&A Expenses | 7.78% | -10.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.65% | 5.30% | |||
| Operating Income | 156.48% | 50.17% | |||
| Income Before Tax | 101.05% | 36.64% | |||
| Income Tax Expenses | -219.05% | -66.13% | |||
| Earnings from Continuing Operations | 101.83% | 37.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 101.83% | 37.00% | |||
| EBIT | 156.48% | 50.17% | |||
| EBITDA | 391.14% | 72.86% | |||
| EPS Basic | 102.00% | 46.24% | |||
| Normalized Basic EPS | 100.81% | 46.09% | |||
| EPS Diluted | 102.00% | 50.00% | |||
| Normalized Diluted EPS | 100.81% | 46.09% | |||
| Average Basic Shares Outstanding | -12.12% | 17.14% | |||
| Average Diluted Shares Outstanding | -9.42% | 17.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||